Loading clinical trials...
Loading clinical trials...
A Phase 1 Dose Escalation Trial of SKI-G-801 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions
Interventions
SKI-G-801
Locations
2
United States
USC Norris Comprehensive Cancer Center, Clinical Investigations Support Office (CISO), 1441 Eastlake Ave., Rm. 7327
Los Angeles, California, United States
Innovative Clinical Research Institute
Whittier, California, United States
Start Date
February 23, 2018
Primary Completion Date
September 2, 2021
Completion Date
September 2, 2021
Last Updated
February 21, 2024
NCT05564390
NCT03050268
NCT07320235
NCT06439199
NCT06782542
NCT05886049
Lead Sponsor
Oscotec Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions